Adenoviral-mediated up-regulation of Otos, a novel specific cochlear gene, decreases cisplatin-induced apoptosis of cultured spiral ligament fibrocytes via MAPK/mitochondrial pathway

Toxicology. 2008 Jun 3;248(1):33-8. doi: 10.1016/j.tox.2008.03.004. Epub 2008 Mar 20.

Abstract

Previous reports have implicated Otos, a novel specific gene expressed by spiral ligament fibrocytes (SLFs) with unclear functions, as a protective gene for cochlea. However, whether Otos gene could protect SLFs against cisplatin (DDP)-induced apoptosis remains largely unknown. In the present study, we utilized Adenoviral-mediated gene transfection to up-regulate Otos expression in cultured SLFs and further assessed the cell viability and apoptosis as well as possible MAPK and mitochondrial pathways. As expected, the data showed that Otos up-regulation significantly decreased apoptosis of SLFs induced by DDP possibly through activation of ERK and partial inhibition of JNK and mitochondrial pathway but not p-38 pathway, suggesting Otos as a potential protective gene for cochlea and raising the possibility of Otos up-regulation as a promising approach to DDP-induced deafness therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Antineoplastic Agents / toxicity*
  • Apoptosis*
  • Cells, Cultured
  • Cisplatin / toxicity*
  • Cochlea / cytology*
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Proteins / genetics*
  • Rats
  • Transfection
  • Up-Regulation

Substances

  • Antineoplastic Agents
  • Otos protein, rat
  • Proteins
  • Mitogen-Activated Protein Kinases
  • Cisplatin